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1. ~t~duction 
Primary nerve cell cultures contain acetylcholin- 
esterase (AChE: EC 3 .l .1.7) and other special macro- 
molecules associated with cholinergic transmission 
[l--4 J . Cultured chick nerve cells, like cultured 
muscle, have been shown to release AChE into their 
medium [5 $1. The experiments presented here 
examined the levels of activity and release of AChE 
in nerve cell cultures after treatment with di-isopropyl- 
phospho~uoridate (DFP) and acetylchol~e analogs. 
The results confirm that dissociated chick embryo 
spinal cord cells release AC&E and demonstrate hat 
the cells regulate their level of AChE activity in 
response to chemical treatments. 
2. Methods 
2.1. Nerve prepumions 
The spinal cords from day 7-8 White Leghorn 
chick embryos were cut into small fragments and 
incubated with 0.1% trypsin in Hank’s salt solution 
for 30 min at 37’C and dissociated by suction. Cells 
were plated at 1 X lo6 cells/dish onto 35 mm Falcon 
plastic tissue culture dishes treated with 0.1% collagen. 
Cortex and brainstem of day 21 Sprague-Dawley 
rat embryos were dissected out separately. Cells were 
plated at 4.5 X 1 O6 cells/dish onto 60 mm Falcon 
plastic tissue culture dishes as in [7] . 
Cells were grown at 37OC in a humidified atmo- 
sphere of 5% CO* and air. The medium was changed 
every 2 days. 
The medium was 85% basal medium (Eagles) 
EIsevierfNortth-HolIaIld Biomedical Press 
(BME) with 0.1% g~ut~ine, 600 mg% final cont. 
glucose, and 15% fetal calf serum in which chohn- 
esterase activity was inhibited. Chick spinal cord cells 
grown in a medium consisting of 90% nutrient mix- 
ture F-l 2 with Hank’s salt solution plus 1.5 g 
bicarbonate and 10% fetal calf serum yielded similar 
results. Cultures were maintained up to 4 weeks in vitro 
and were routinely observed in the living state with 
an inverted phase contrast microscope. 
Fetal calf serum was incubated with 0.1 mM DFP, 
an irreversible inhibitor of chol~estera~ enzymes [8] 
to inhibit endogenous cholinesterase activity. DFP 
was added 3 times and after each addition, the serum 
was incubated for 8 h at 37°C. Cholinesterase. activity 
was 95% inhibited and there was no detectable DFP 
activity. Acrylamide gel electrophoresis was based on 
the methods in 193. 
2.2. Enzyme analysis 
Localization of AChE was studied cytochemically 
by the technique in [lo] , after 5 min fmation in 4% 
form~dehyde (v/v). AChE and nonspecific holin- 
esterase (BChE) activities were determ~ed on rinsed 
and sonicated cultures using the spectrophotomet~c 
assay in [ 1 I] . AChE activities are expressed as units 
of activity @mol thiocholine ster hydrolyzed/mm/ 
culture dish). 
Samples were assayed with acetylthiocholine iodide 
(ACTC) and butyrylthiocholine iodide (BUTC) as the 
substrates, with the specific AChE inhibitor 284~51 
(10 PM) and with the non-specific holinesterase 
inhibitor iso-OMPA (100 PM). There was only trace 
enzyme activity with BUTC as substrate or with ACTC 
in the presence of 284~51. Samples run with and 
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without iso-OMPA had virtually the same activity, 
indicating that over 95% of the esterase activity in 
these experiments was AChE. 
2.3. DFP treatment 
Cell cultures were rinsed 4 times at 37’C with saline 
and incubated with a saline solution of 0.1 mM DFP 
for 10 min at room temperature, rinsed 4 times with 
saline and returned to the complete medium at 37°C. 
At this time, in some dishes, cycloheximide at final 
cont. 10 ,uM, acetylcholine, choline or acetylbeta- 
methylcholine (@MC) at final cont. 5 mM, or 10 Ci 
[ 3H]leucine were added and samples were taken at 
various time intervals. 
2.4.Drugs 
ACTC, BUTC, DTNB, iso-OMPA, DFP, cyclo- 
heximide, acetylcholine, choline and @MC were 
purchased from Sigma Chemicals, 1:2.50 trypsin from 
Difco Lab, F-l 2 and Hank’s powdered medium from 
Gibco, fetal calf serum from Irvine Scientific, Grade A 
collagen from Calbiochem, and [ 3H]leucine from 
ICN Corp. 
Chick cultures were prepared and examined at the 
University of California, Davis. Rat cultures were 
prepared at UCLA, sampled, and sent frozen to UC 
Davis for analysis and interpretation. 
3. Results 
Initially, cells from chick spinal cord appeared 
round and morphologically undifferentiated. Within 
2-3 days in vitro many cells developed long axon- 
like processes. After 5-7 days these neural cells 
formed a network of interconnecting processes with 
groups of round cells between them. Between 7-20 
days some of the nerve cells became larger and 
exhibited thickened axons while others stayed small 
and extended thin processes. Flattened, morpho- 
logically undifferentiated cells appeared inthe cultures 
and increased greatly in number with time. Only the 
neural cells showed any activity when these various 
cells were stained for AChE. 
AChE activity of the cells was low at first; it 
increased uring the first week in culture and then 
remained relatively constant for at least 24 days. The 
AChE activities found in a typical experiment, shown 
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in fig.1, rose to -7 X 1 Oe3 units/min/dish in the first 
week. 
Figure 1 also shows the amounts of AChE that 
appeared in the medium during the 2-day intervals 
between medium changes. In this, and in 3 other 
experiments not shown here, the total AChE activity 
released by the cells was greater than that which they 
retained. Irr the experiment shown here, the mean 
ratio of AChE released to that retained by the cells 
over 48 h averaged 4.5 : 1 with a range of 2.5 : 1 to 
11 : 1. Cells continued to produce AChE at a high 
rate for as long as the cultures were maintained, and 
most of this AChE was released into the medium. 
Acrylamide lectrophoresis showed 3 bands of AChE 
activity in both the cells and medium. 
A series of 5 experiments was performed to examine 
the recovery of nerve-cell AChE from acute treatment 
with DFP. The ISo of DFP for AChE from 14-day 
Fig.1. AChE production in spinal cord cells. The lower bar 
graph compares AChE activity measured in spinal cord cells 
(hatched bars) to the activity released into the medium (clean 
bars) every 2 days. The upper line graph represents cumula- 
tive AChE activity for the 24 day period. Values are the 
averages of 3 dishes. 
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Table 1 Table 2 
Recovery of AChE of DFP-treated nerve cells (lo-14 day 
old cultures) 
Effect of &MC on DFP-treated nerve cells 
Activity (X 10-4)a 
% Initial activitya 
Oh lh 2h 4h 8h 24 h 
8.25 14.5 44.0 65.0 80.5 79.5 
k1.26 +12.0 +15.3 
(4) (2) (4) (2) (2) (4) 
a Values are means f standard deviations when appropriate 
Number of experiments given in parentheses. Duplicate or 
triplicate samples were taken for each experiment. Activities 




0 No DFP 20.8 0 20.8 
(2) DFP 7.0 0 7.0 
24 No DFP 21.4 f 3.5 8.1 
(3) DFP 22.6 f 5.9 8.6 
A@MC 23.5 * 6.0 22.5 
48 No DFP 21.0 -t 3.3 43.1 
(3) DFP 26.8 f 2.0 35.5 
APMC 36.4 i 7.1 63.0 
nerve cultures was -1 X 10e7 M, and concentrations 
of 1 X lo-’ M DFP and above inhibited greater than 
90% of the AChE activity. The results of 4 separate 
experiments are compiled in table 1. AChE rapidly 
returned to 44% of its initial activity in 2 h and then 
increased more slowly to -80% of its original activity 
within 8 h. Release of AChE into the medium was not 
detected 8h or 12 h after DFP treatment, The amount 
of AChE released into the medium at 24 h averaged 
OS-times and in one experiment at 48 h Gas 2.5times 
the activity of the cells. 
a Values are means f standard deviations when appropriate. 
Number of samples are given in parentheses. Activities are 
pmol ACTC hydrolyzed/min/dish 
b Significantly different from DFP values at P <.05 
Table 3 
Effects of AChE and choline on DFP-treated nerve cells 
Activity (X 10b4) 
Addition of 10 PM cycloheximide to the cells 
immediately after treatment with DFP resulted in a 
reduction of 92-95% in the AChE found at 24 h 
(2 experiments), and a 97% decrease in incorporation 




0 No DFP 42.7 0 42.7 
DFP 3.16 0 3.16 
DFP-treated cells were used to examine the effects 
of MMC, ACh, and choline on the AChE activity of 
nerve cell cultures. The results of an experiment in 
which 5 mM A/3MC was added to day 10 nerve 
cultures are shown in table 2. Total AChE activity 
increased 1S-times by the presence of ApMC during 
the 48 h experiment. Cell AChE activity increased 
1.4-times during the same interval. 
8 DFP 38.7 0 38.7 
ACh 39.4 0 39.4 
Choline 34.7 0 34.7 
12 DFP 23.6 0 23.6 
ACh 34.1 21.3 55.4 
Choline 47.6 25.7 73.3 
A similar experiment conducted with ACh and 
choline is shown in tables 3 and 4. There was a linear 
increase in AChE activity for at least 48 h after DFP 
treatment (correlation coefficients were 0.97 and 
above for all groups), and the presence of ACh resulted 
in - 1.4-times more activity than the controls. 
(Increased values of AChE with choline were not 
statistically significant.) 
24 DFP 37.6 25.7 63.3 
ACh 44.1 55.9 100 
Choline 49.1 30.1 79.2 
48 DFP 51.5 136 188 
ACh 92.8 169 262 
Choline 61.9 178 240 
(5 X 10e3 M substrates; duplicate samples; activity in pmol 
ACTC hydrolysed/min/dish) 
Medium Total 
29.8 + 6.0 
31.2 f 12.4 
46.0 i 12.7 
64.1 ?: 5.3 
62.3 i 9.6 
99.3 f 18.6b 
Medium Total 
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Table 4 





a Significantly different from DFP-treated cells, P <0.5, 
F= 166 [1,3] 
(Data from same cultures as in Table 3. Linear egressions 
calculated forO-48 h) 
Release of AChE into the medium was detected 
earlier (12 h) for ACh- and choline-treated cells than 
with the DFP-treated controls (24 h). 
To see if other nerve cells released AChE in culture, 
AChE activity was measured in cells from the cortex 
and brain stem of embryonic rats grown in the labora- 
tory of Dr Jean de Vellis. Week 4 cultures developed 
morphologically differentiated neurons, but produced 
virtually no measureable AChE or BChE in either cells 
or medium. 
4. Discussion 
The results reported here, some of which were 
presented in preliminary form [S] , and the report 
[6] , demonstrate hat AChE is released in quantity 
from cultured chick-nerve cells. The AChE activity 
retained by the cells studied here was only a relatively 
small portion of the total AChE produced. 
Studies of embryonic muscle cultures, denervated 
muscle and dystrophic muscle of the chicken show 
that AChE appears in the culture medium or in tissue 
fluids whenever its activity in muscle is high [ 121 ,
AChE has been demonstrated in chickembryo serum 
[ 131, and in the cerebrospinal fluid of mammals [14] . 
AChE has been proposed to be [ 15,161 actively secreted 
by cells in the adrenals and in the central nervous ystem 
of mammals. A 10 S form of AChE was released from 
rat sympathetic ganglia explants [171 .
The physiological significance of the release of 
AChE from nerve and muscle systems may lie in the 
fact that the enzyme is probably in the basement 
membrane material at the synaptic left, outside of 
the muscle and nerve cells themselves [ 18,191 . It is 
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possible that its release from nerve provides at least 
some of the enzyme at the motor end plate. 
The DFP experiments demonstrate hat cultured 
nerve rapidly recovers much of its AChE after it has 
been inhibited by an irreversible organophosphate 
agent. The lack of recovery of enzyme activity in the 
presence of cycloheximide suggests hat the increase 
is due to synthesis of new enzyme. Approximately 
50% of the AChE recovered in 2 h. In situ, AChE of 
mammalian brain recovered with a half-life of 7-16.5 
days with DFP [20] . The activity of a low molecular 
weight formof AChE rapidly reappeared in mamma- 
lian retina after DFP treatment [21] , and complete 
recovery of AChE to control values in 4 h using sub- 
acute doses of parathion was shown [22]. 
Brief treatments of cultured muscle with DFP or 
with paraoxon are also followed by rapid recovery of 
enzyme activity [23,24] .The kinetics of the recovery 
suggest that AChE is rapidly synthesized and degraded 
by the cells [23] and that the rapidity of the recovery 
is dependent on the extent of inhibition, i.e., the more 
enzyme inhibited, the more rapid the recovery [24] . 
MMC and ACh dramatically increased the AChE 
activity of the nerve cultures tudies here, particularily 
after 48 h incubation. ACh protected cultured chick 
spinal cord explants from loss of AChE [25] , but the 
values of AChE in the medium were not determined. 
AChE increased when ACh was perfused into retinas 
following DFP treatment [26] . 
A/3MC and ACh increased the AChE activity of 
chickembryo muscle cell cultures [27,28] .The 
effect was not an ‘induction‘, i.e., it was not inhibited 
by actinomycin D. However, it was blocked by the 
addition of curare, as if it were mediated by ACh 
receptor. The modulation of ACh receptor and AChE 
activities in muscle cultures has been associated with 
‘activity’ of the cultures [27,29,30] . Whether or not 
contraction itself is necessary to regulate AChE and 
ACh receptor of muscle is not known. The results 
presented here for nerve cultures how that regulation 
of AChE levels by ACh and ACh analogs need not be 
contraction-mediated. One possibility is that move- 
ment of ions plays a regulatory role in controlling 
levels of AChE and ACh receptor. These findings with 
cultured muscle and nerve raise the possibility that 
release of ACh at synapses and at the neuromuscular 
junction plays a role in maintaining the levels of AChE 
and ACh receptor. 
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